Ata Firouzi
Overview
Explore the profile of Ata Firouzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maadani M, Ardestani S, Rafiee F, Rezaei-Kalantari K, Rabiee P, Kia Y, et al.
Vasc Specialist Int
. 2025 Feb;
41:2.
PMID: 39994502
The radial artery is currently the main vascular access site for cardiac catheterization. Radial artery occlusion (RAO), although a relatively silent complication, raises concerns because of its potential impact on...
2.
Jenab Y, Sadeghipour P, Mohseni-Badalabadi R, Kaviani R, Hosseini K, Pasebani Y, et al.
EuroIntervention
. 2025 Jan;
21(1):82-92.
PMID: 39773831
Background: The role of direct oral anticoagulants (DOACs) in the treatment of left ventricular thrombus (LVT) after ST-elevation myocardial infarction (STEMI) remains uncertain. Aims: We aimed to compare the effect...
3.
MozafaryBazargany M, Khalili Pour E, Shamsedini A, Banifatemeh S, Azimi A, Manavishad A, et al.
Sci Rep
. 2024 Dec;
14(1):31090.
PMID: 39730798
We compared chorioretinal microvascular of Slow Coronary Flow Phenomenon (SCFP) patients using Optical Coherence Tomography Angiography (OCTA) to healthy controls. We recruited 21 patients from September 2023 until January 2024...
4.
Alizadehasl A, Firouzi A, Hajiali Fini H, Firoozbakhsh P, Dokhani N, Shourmeij R
J Tehran Heart Cent
. 2024 Dec;
19(1):66-69.
PMID: 39712363
Cancer is the second leading cause of death worldwide, and pericardial effusion is relatively common in these patients. What constitutes the best therapeutic method for treating pericardial effusion in patients...
5.
Rosenthal E, Qureshi S, Sivakumar K, Jones M, Yong S, Kabir S, et al.
Circulation
. 2024 Dec;
PMID: 39697167
Background: Covered stent correction for a sinus venosus atrial septal defect (SVASD) was first performed in 2009. This innovative approach was initially viewed as experimental and was reserved for highly...
6.
Zahedmehr A, Dousti A, Alemzadeh-Ansari M, Gharibzadeh A, Sheibani M, MozafaryBazargany M, et al.
Heliyon
. 2024 Nov;
10(20):e39451.
PMID: 39502239
Background: The radial approach is now recommended as the default strategy in diagnostic coronary angiography and percutaneous coronary intervention. Radial artery occlusion (RAO) is the most common complication that limits...
7.
Firouzi A, Ghaffari Jolfayi A, Shamsedini A, Bagheri Y, Memarjafari M, Shemshadi S, et al.
Acta Cardiol
. 2024 Oct;
79(9):1030-1033.
PMID: 39387269
Paravalvular leaks (PVL) following mitral valve replacement occur in 7% to 17% of cases, with 1% to 5% being clinically significant. Although surgical repair is often recommended, transcatheter PVL closures...
8.
Alizadehasl A, Firouzi A, Khajali Z, Khalilipur E, Hosseini Z, Nezhadbahram H, et al.
J Cardiovasc Thorac Res
. 2024 Sep;
16(2):135-141.
PMID: 39253348
Most cases of congenital coronary artery fistula (CAF) resolve spontaneously, symptomatic patients with severe shunting require surgical intervention. Our aim is to evaluate success rate and outcome of CAFs treatment...
9.
Mortezaeian H, Firouzi A, Ebrahimi P, Anafje M, Bashghareh P, Doung P, et al.
Int J Emerg Med
. 2024 Aug;
17(1):102.
PMID: 39210259
Background: Percutaneous pulmonary valve implantation (PPVI) is a recognized alternative treatment to surgery for patients with dysfunctional right ventricular outflow tracts. Patient selection is essential to avoid serious complications from...
10.
Rostambeigi S, Mazaherinia H, Mahmoudi Hamidabad N, Kelsey A, Alizadehasl A, Harandi S, et al.
BMC Cardiovasc Disord
. 2024 Jun;
24(1):309.
PMID: 38890637
Background: Percutaneous balloon mitral valvuloplasty (PBMV) is the ACC/AHA class I recommendation for treating symptomatic rheumatic mitral stenosis with suitable valve morphology, less than moderate MR and absence of left...